Eton Pharmaceuticals (ETON) Intangibles (2019 - 2025)

Eton Pharmaceuticals has disclosed Intangibles across 7 years of filings, most recently posting $30.9 million for Q4 2025.

• Intangibles for Q4 2025 came in at $30.9 million, down 17.13% year-over-year; the trailing twelve-month figure through Dec 2025 was $30.9 million (down 17.13% YoY), and the FY2025 annual result was $30.9 million, down 17.13% from the prior year.
• Intangibles came in at $30.9 million for Q4 2025 at Eton Pharmaceuticals, down from $31.9 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $37.3 million in Q4 2024 to a low of $463000.0 in Q3 2021.
• The 5-year median for Intangibles is $4.7 million (2022), against an average of $11.3 million.
• Across the five-year window, Intangibles fell 24.35% in 2021 and jumped 974.08% in 2022, its largest moves.
• Eton Pharmaceuticals' Intangibles stood at $3.6 million in 2021, then soared by 31.29% to $4.8 million in 2022, then fell by 0.32% to $4.7 million in 2023, then surged by 686.28% to $37.3 million in 2024, then dropped by 17.13% to $30.9 million in 2025.
• The last three Intangibles figures came in at $30.9 million (Q4 2025), $31.9 million (Q3 2025), and $32.9 million (Q2 2025), per Business Quant data.